Showing results (31-40 of 301) with videos related to
Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|June 24, 2014
Radiopharmaceutical therapy in the era of precision medicineGeorge Sgouros, David M GoldenbergMolecular Cancer Therapeutics|January 7, 2005
A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapyRhona Stein, David M GoldenbergTherapeutics and Clinical Risk Management|May 14, 2008
Targeting CD22 as a strategy for treating systemic autoimmune diseasesThomas Dörner, David M GoldenbergExpert Opinion on Biological Therapy|June 2, 2012
Using antibodies to target cancer therapeuticsDavid M Goldenberg, Robert M SharkeyExpert Opinion on Emerging Drugs|September 11, 2010
New agents and approaches to the treatment of B-cell non-Hodgkin lymphomaJack D Burton, David M GoldenbergJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Perspectives on cancer therapy with radiolabeled monoclonal antibodiesRobert M Sharkey, David M GoldenbergExpert Opinion on Biological Therapy|June 12, 2012
Designing immunoconjugates for cancer therapySerengulam V Govindan, David M GoldenbergMabs|June 19, 2019
Antibody-drug conjugates targeting TROP-2 and incorporating SN-38: A case study of anti-TROP-2 sacituzumab govitecanDavid M Goldenberg, Robert M SharkeyMolecular Cancer Therapeutics|February 20, 2007
Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenograftsAlice P Taylor, David M GoldenbergMolecular Biotechnology|April 17, 2007
Methods and goals for the use of in vitro and in vivo chemosensitivity testingRosalyn D Blumenthal, David M GoldenbergPageof 31